Product Details

Jamp Linezolid

Linezolid
600 mg
Tablet


DIN/PIN/NPN

02520354

Manufacturer

Jamp Pharma Corporation

Formulary Listing Date

2023-01-31  

Unit Price

19.3041

Amount MOH Pays

19.3041

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

J01XX08

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02243684 Zyvoxam NA NA
02422689 Sandoz Linezolid 19.3041 19.3041
02426552 Apo-Linezolid 19.3041 19.3041
02520354 Jamp Linezolid 19.3041 19.3041
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
362 1 year

For the treatment of patients with:

Methicillin-resistant Staphylococcus species (MRSA, MRSE) infections* in patients who are intolerant or have failed vancomycin therapy, or have contraindications to venous access.

*Infections must be documented and culture proven. Not approved for colonization (e.g. nares, urine, etc). Maximum 28 days supply.

363 1 year

For the treatment of patients with:

Vancomycin resistant Enterococcus species (VRE) infections* in patients switching from IV linezolid.

*Infections must be documented and culture proven. Not approved for colonization (e.g., nares, urine, etc.). Maximum 28 days supply.

364 1 year

Step-down therapy for the treatment of methicillin-resistant Staphylococcus species or vancomycin resistant Enterococcus species (VRE) infections* after parenteral therapy or hospital/ emergency department discharge.

*Infections must be documented and culture proven. Not approved for colonization (e.g. nares, urine, etc). Maximum 28 days supply.

 

EAP Criteria

Therapeutic Class Reimbursement Criteria
Unclassified EAP Drugs

These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition

Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding.

Product Monograph

View Monograph